CeliVax Technology
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Technical Competence
Fast and robust manufacturing process
Because CeliVax uses B cells, NK cells and monocytes from a patient’s blood, no additional cell culture process is required, which allows for a fast and efficient manufacturing process.
